Integrating machine learning and genomics to drive discovery and predict outcomes for newly diagnosed and relapsed/refractory T-cell and NK-cell lymphomas.
Connecting oncologists and scientists across the globe to leverage global expertise in tackling these rare and aggressive diseases.
PETAL focuses on health disparities by including high-, middle- and low-income countries to capture diverse patient populations to help make access to drugs and education equitable. We @PETAL believe that no patient should be left behind.
Our goal at PETAL is to enable personalized treatments to improve patient lives and create an infrastructure through this alliance for future studies including clinical trials to test novel treatments in rare diseases.

PETAL Consortium

Org chart

Teams

Offices